ClinicalTrials.Veeva

Menu

Percutaneous Peripheral Nerve Stimulation and Performance

U

Universidad Rey Juan Carlos

Status

Completed

Conditions

Sports Physical Therapy

Treatments

Device: Percutaneous Peripheral Nerve Stimulation
Other: Control Group

Study type

Interventional

Funder types

Other

Identifiers

NCT04427553
URJC-UAX-02-2020

Details and patient eligibility

About

Percutaneous Peripheral Nerve Stimulation is a relative new intervention applied by physical therapists. Although it has been hypothesized that this technique could improve pain and function, no studies have investigated changes in physical performance in soccer players. This study will evaluate changes in physical performance after the application of Percutaneous Peripheral Nerve Stimulation in a sample of healthy soccer players.

Enrollment

20 patients

Sex

Male

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Semiprofessional soccer player
  • No symptoms or injury in the lower extremity previous 6 months
  • Training frequency of at least 3 days a week plus soccer game

Exclusion criteria

  • fear to needles
  • presence of pain or any musculoskeletal disease
  • previous surgery in the lower extremity
  • underlying medical conditions, e.g., diabetes, hypertension

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

20 participants in 2 patient groups, including a placebo group

Percutaneous Peripheral Nerve Stimulation
Experimental group
Description:
Participants assigned to this group will received two sessions (once per week) of ultrasound guided Percutaneous Peripheral Nerve Stimulation targeting the femoral nerve. We will apply a biphasic compensated electrical current at a frequency of 10 Hz, a pulse width of 240 µs and intensity allowed over a pain-free motor threshold (muscle contraction). Each participant will receive 10 repetitions of 10 seconds each one with 10 seconds rest- period between series (total treatment session 1.40 min). After that participants will walk during 3 minutes.
Treatment:
Device: Percutaneous Peripheral Nerve Stimulation
Control
Placebo Comparator group
Description:
Participants in the control group will walk during 5 minutes, without receiving any intervention
Treatment:
Other: Control Group

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems